Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries
Sr. Advisor/Director - Process engineering -Peptides/Small molecule Scientist
About Eli Lilly
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
Total Views
1
Total Apply Clicks
0
Total Mock Apply
0
Total Bookmarks
0
Similar jobs
Lead Software Engineer - Java, Spring Boot, Apache Kafka, AWS
JPMorgan Chase · India, IN
HW Technical Lead (RF/Wi-Fi)
Nokia · India, IN
Multidisciplinary Manager, Software Engineering
Microsoft · India, Karnataka, Bangalore
Technical Lead
HCL Technologies · India
CPU Design Verification Lead/Engineer
Intel · India, Bangalore
About Eli Lilly
Eli Lilly
PublicEli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
10,001+
Employees
India
Headquarters
$588B
Valuation
Reviews
10 reviews
3.8
10 reviews
Work-life balance
3.2
Compensation
4.1
Culture
3.7
Career
2.8
Management
3.9
72%
Recommend to a friend
Pros
Excellent compensation and benefits
Supportive management and leadership
Flexible work arrangements
Cons
Limited career advancement opportunities
High stress and demanding workload
Fast-paced and high-pressure environment
Salary Ranges
56 data points
Mid/L4
Senior/L5
Mid/L4 · Advisor - Research - Statistics
1 reports
$167,900
total per year
Base
$146,000
Stock
-
Bonus
-
$167,900
$167,900
Interview experience
2 interviews
Difficulty
2.5
/ 5
Duration
14-28 weeks
Offer rate
100%
Experience
Positive 50%
Neutral 50%
Negative 0%
Interview process
1
Application Review
2
HR Screen
3
Phone/Video Interview
4
Hiring Manager Interview
5
Final Interview/Panel
6
Offer
Common questions
Behavioral/STAR
Past Experience
Culture Fit
Industry Knowledge
Technical Knowledge
Latest updates
Eli Lilly: A Heavyweight Battle Isn't Won In Round 1 (NYSE:LLY) - Seeking Alpha
Seeking Alpha
News
·
1w ago
Why Eli Lilly (LLY) Shares Are Trading Lower Today - StockStory
StockStory
News
·
1w ago
A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B - statnews.com
statnews.com
News
·
1w ago
Lilly's obesity pill records modest second week as battle with Novo intensifies - Reuters
Reuters
News
·
1w ago